Renaissance Capital logo

MNX News

Nearly 80% of the year’s large IPOs are above issue, a positive signal for the fall IPO market

CAVA

The year's crop of large IPOs is off to a strong start, with nearly 80% currently above issue. As long as these solid returns hold, we expect a decent harvest of public listings in the fall. So far this year, 19 IPOs have raised $100 million or more, outpacing all of 2022 (16 IPOs), but still well below the 10-year median of about 70 sizable IPOs at this point in a year. 2023&rsquo...read more

US IPO Week Ahead: Surf Air Mobility plans the year’s first direct listing as July comes to a close

SRFM

Two deals are currently on the calendar for the week ahead, only one of which qualifies for inclusion in our stats. One SPAC is also tentatively scheduled to price. After scrapping plans for a SPAC merger in 2022, aviation company Surf Air Mobility (SRFM) is slated to begin trading on the NYSE in the first direct listing of 2023. Surf Air provides a regional air...read more

US IPO Weekly Recap: May IPO market ends with a quiet week

CAVA

There were no IPOs this past week, as the sole scheduled offering (AZTR) delayed to the week ahead. Along with no post-Memorial Day launches, the pipeline was quiet with no new initial filings. The summer IPO market is off to a slow start coming out of May, which was the year’s slowest month for IPOs to date but also ...read more

US IPO Week Ahead: Post-Memorial Day IPO calendar is quiet for now

AZTR

Just one small holdover is scheduled to price in the short holiday week ahead. Azitra (AZTR) plans to raise $12 million at a $70 million market cap. The biotech’s pipeline is led by a genetically modified strain of bacteria targeting orphan disease Netherton syndrome. Azitra’s lead candidate is expected to enter a Phase 1b trial in the 1H23, and the...read more